Access cutting-edge sars cov-2 post-acute sequelae treatment through this clinical trial at a research site in Chapel Hill. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Chapel Hill location
Preparing your pre-screening questions…
Access sars cov-2 post-acute sequelae specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sars cov-2 post-acute sequelae treatment provided free
Check if you qualify for this sars cov-2 post-acute sequelae clinical trial in Chapel Hill, NC
No-Cost Study Care
Local to Chapel Hill
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect information about participants' health and symptoms through questionnaires and may collect saliva and other non-invasive oral samples. The study will also examine biological factors in these samples that may be associated with persistent symptoms. The goal is to better understand why some people develop Long COVID and identify factors that may help predict who is more likely to experience persistent symptoms.
Sponsor: University of North Carolina, Chapel Hill
Yes, this clinical trial (NCT07781501) has an active research site in Chapel Hill, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for sars cov-2 post-acute sequelae treatment options in Chapel Hill, NC, this clinical trial (NCT07781501) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chapel Hill research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sars cov-2 post-acute sequelae specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.